Use of Rokitamycin Dry Syrup in Cases of Upper Deep Cervical Lymphadenitis and Otitis Media with Exudatives

DOI Web Site PubMed
  • MUKAI Susumu
    Medical Legal Person Kasei-kai Mukai Medical Clinic Medical Legal Person Kasei-kai Mukai Microbiological Laboratory
  • ASAOKA Kazuyuki
    Medical Legal Person Kasei-kai Mukai Medical Clinic
  • MURAKAMI Setsuko
    Medical Legal Person Kasei-kai Mukai Medical Clinic
  • SUZUKI Issei
    Medical Legal Person Kasei-kai Mukai Microbiological Laboratory
  • MUKAI Chikako
    Medical Legal Person Kasei-kai Mukai Medical Clinic

Bibliographic Information

Other Title
  • Chlamydia感染による上深頸部リンパ節炎および滲出性中耳炎に対するRokitamycin Dry Syrupの使用経験
  • Chlamydia感染による上深頚部リンパ節炎および滲出性中耳炎に対するRokitamycin Dry Syrupの使用経験
  • Chlamydia カンセン ニ ヨル ジョウ シンケイブ リンパセツエン オ

Search this article

Abstract

Dry syrup of Rokitamycin (RKM? DS), a new macrolide antibiotic with 16-membered ring developed by Toyo Jozo Co., Ltd., was used on cases of upper deep cervical lymphadenitis (UDCL) and of otitis media with exudatives (OME) likely caused by chlamydia infections, and its clinical effects were investigated.<BR>1) In four cases of UDCL (C. psittaci infections), daily doses of 20.0-28.6 mg/kg were administered for 10-42 consecutive days and good efficacies were observed with two cases of excellent results and two cases of good results.<BR>2) In one case of OME (C. trachomatis infection) a daily dose of 30.0 mg/kg was administered for 15 consecutive days and good effectiveness was observed.<BR>3) No side effect was observed in any of the cases.<BR>From the above results, it became clear that RKM·EDS could effectively used as a therapeutic agent for UDCL and OME in children.

Journal

  • Kansenshogaku Zasshi

    Kansenshogaku Zasshi 63 (2), 98-102, 1989

    The Japanese Association for Infectious Diseases

Keywords

Details 詳細情報について

Report a problem

Back to top